Cargando…

Effects of ghrelin supplementation on the acute phase of Chagas disease in rats

BACKGROUND: Trypanosoma cruzi is the causative agent of Chagas disease, which is endemic to subtropical and tropical Americas. The disease treatment remains partially ineffective, involving therapies directed to the parasite as well as palliative strategies for the clinical manifestations. Therefore...

Descripción completa

Detalles Bibliográficos
Autores principales: de Paula Silva, Ferdinando, da Costa, Cássia Mariana Bronzon, Pereira, Luiz Miguel, Lessa, Diego Fernando Silva, Pitol, Dimitrius Leonardo, Issa, João Paulo Mardegan, do Prado Júnior, José Clóvis, Abrahão, Ana Amélia Carraro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6842500/
https://www.ncbi.nlm.nih.gov/pubmed/31706334
http://dx.doi.org/10.1186/s13071-019-3787-y
_version_ 1783468053256732672
author de Paula Silva, Ferdinando
da Costa, Cássia Mariana Bronzon
Pereira, Luiz Miguel
Lessa, Diego Fernando Silva
Pitol, Dimitrius Leonardo
Issa, João Paulo Mardegan
do Prado Júnior, José Clóvis
Abrahão, Ana Amélia Carraro
author_facet de Paula Silva, Ferdinando
da Costa, Cássia Mariana Bronzon
Pereira, Luiz Miguel
Lessa, Diego Fernando Silva
Pitol, Dimitrius Leonardo
Issa, João Paulo Mardegan
do Prado Júnior, José Clóvis
Abrahão, Ana Amélia Carraro
author_sort de Paula Silva, Ferdinando
collection PubMed
description BACKGROUND: Trypanosoma cruzi is the causative agent of Chagas disease, which is endemic to subtropical and tropical Americas. The disease treatment remains partially ineffective, involving therapies directed to the parasite as well as palliative strategies for the clinical manifestations. Therefore, novel candidates for disease control are necessary. Additionally, strategies based on parasite inhibition via specific targets and application of compounds which improve the immune response against the disease is welcomed. Ghrelin is a peptide hormone pointed as a substance with important cardioprotective, vasodilatory, anti-apoptotic, anti-oxidative and immune modulatory functions. The aims of this study were to evaluate the immunomodulatory effects of ghrelin in male Wistar rats infected with the Y strain of T. cruzi. METHODS: In order to delineate an immune response against T. cruzi mediated by ghrelin, we evaluated the following parameters: quantification of blood and cardiac parasites; analysis of cell markers (CD3(+), CD8(+), NK, NKT, CD45RA(+), macrophage and RT1B(+)); nitric oxide (NO) production; lymphoproliferation assays; splenocyte apoptosis; and INF-γ, IL-12 and IL-6 quantification in sera. RESULTS: The animals infected with T. cruzi and supplemented with ghrelin demonstrated an upregulated pattern in macrophage and NO production, whereas an anti-inflammatory response was observed in T cells and cytokines. The low response against T. cruzi mediated by T cells probably contributed to a higher colonization of the cardiac tissue, when compared to infected groups. On the other side, the peptide decreased the inflammatory infiltration in cardiac tissue infected with T. cruzi. CONCLUSIONS: Ghrelin demonstrated a dual function in animals infected with T. cruzi. Further studies, especially related to the decrease of cardiac tissue inflammation, are needed in order to determine the advantages of ghrelin supplementation in Chagas disease, mostly for populations from endemic areas.
format Online
Article
Text
id pubmed-6842500
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-68425002019-11-14 Effects of ghrelin supplementation on the acute phase of Chagas disease in rats de Paula Silva, Ferdinando da Costa, Cássia Mariana Bronzon Pereira, Luiz Miguel Lessa, Diego Fernando Silva Pitol, Dimitrius Leonardo Issa, João Paulo Mardegan do Prado Júnior, José Clóvis Abrahão, Ana Amélia Carraro Parasit Vectors Research BACKGROUND: Trypanosoma cruzi is the causative agent of Chagas disease, which is endemic to subtropical and tropical Americas. The disease treatment remains partially ineffective, involving therapies directed to the parasite as well as palliative strategies for the clinical manifestations. Therefore, novel candidates for disease control are necessary. Additionally, strategies based on parasite inhibition via specific targets and application of compounds which improve the immune response against the disease is welcomed. Ghrelin is a peptide hormone pointed as a substance with important cardioprotective, vasodilatory, anti-apoptotic, anti-oxidative and immune modulatory functions. The aims of this study were to evaluate the immunomodulatory effects of ghrelin in male Wistar rats infected with the Y strain of T. cruzi. METHODS: In order to delineate an immune response against T. cruzi mediated by ghrelin, we evaluated the following parameters: quantification of blood and cardiac parasites; analysis of cell markers (CD3(+), CD8(+), NK, NKT, CD45RA(+), macrophage and RT1B(+)); nitric oxide (NO) production; lymphoproliferation assays; splenocyte apoptosis; and INF-γ, IL-12 and IL-6 quantification in sera. RESULTS: The animals infected with T. cruzi and supplemented with ghrelin demonstrated an upregulated pattern in macrophage and NO production, whereas an anti-inflammatory response was observed in T cells and cytokines. The low response against T. cruzi mediated by T cells probably contributed to a higher colonization of the cardiac tissue, when compared to infected groups. On the other side, the peptide decreased the inflammatory infiltration in cardiac tissue infected with T. cruzi. CONCLUSIONS: Ghrelin demonstrated a dual function in animals infected with T. cruzi. Further studies, especially related to the decrease of cardiac tissue inflammation, are needed in order to determine the advantages of ghrelin supplementation in Chagas disease, mostly for populations from endemic areas. BioMed Central 2019-11-09 /pmc/articles/PMC6842500/ /pubmed/31706334 http://dx.doi.org/10.1186/s13071-019-3787-y Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
de Paula Silva, Ferdinando
da Costa, Cássia Mariana Bronzon
Pereira, Luiz Miguel
Lessa, Diego Fernando Silva
Pitol, Dimitrius Leonardo
Issa, João Paulo Mardegan
do Prado Júnior, José Clóvis
Abrahão, Ana Amélia Carraro
Effects of ghrelin supplementation on the acute phase of Chagas disease in rats
title Effects of ghrelin supplementation on the acute phase of Chagas disease in rats
title_full Effects of ghrelin supplementation on the acute phase of Chagas disease in rats
title_fullStr Effects of ghrelin supplementation on the acute phase of Chagas disease in rats
title_full_unstemmed Effects of ghrelin supplementation on the acute phase of Chagas disease in rats
title_short Effects of ghrelin supplementation on the acute phase of Chagas disease in rats
title_sort effects of ghrelin supplementation on the acute phase of chagas disease in rats
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6842500/
https://www.ncbi.nlm.nih.gov/pubmed/31706334
http://dx.doi.org/10.1186/s13071-019-3787-y
work_keys_str_mv AT depaulasilvaferdinando effectsofghrelinsupplementationontheacutephaseofchagasdiseaseinrats
AT dacostacassiamarianabronzon effectsofghrelinsupplementationontheacutephaseofchagasdiseaseinrats
AT pereiraluizmiguel effectsofghrelinsupplementationontheacutephaseofchagasdiseaseinrats
AT lessadiegofernandosilva effectsofghrelinsupplementationontheacutephaseofchagasdiseaseinrats
AT pitoldimitriusleonardo effectsofghrelinsupplementationontheacutephaseofchagasdiseaseinrats
AT issajoaopaulomardegan effectsofghrelinsupplementationontheacutephaseofchagasdiseaseinrats
AT dopradojuniorjoseclovis effectsofghrelinsupplementationontheacutephaseofchagasdiseaseinrats
AT abrahaoanaameliacarraro effectsofghrelinsupplementationontheacutephaseofchagasdiseaseinrats